HUTCHMED Ltd. is a company based in Hong Kong that discovers, develops, and commercializes targeted therapies and immunotherapies for cancer and immunological diseases. Its main segments are Oncology/Immunology and Other Ventures, with multiple products in development to target specific cancers such as breast, lung, colorectal, gastric, pancreatic NET, and many others. HUTCHMED has formed partnerships with several other companies to further its research and development efforts.